Stepan Company
NYSE:SCLChemicals - Specialty
+$0.46 today
- Market cap
- $1.50B
- Beta
- 0.97
- P/E (TTM)
- -87.3
- EPS (TTM)
- -$0.62
- Dividend yield
- 2.89%
Volume 0.13M
Average 0.15M
SCL Total Current Liabilities
All obligations due within one year.
Stepan CompanyNYSE: SCL
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 2.6% from a year ago
Total current liabilities stood at $720.45M at the end of Q1 FY2026, down 2.6% from a year earlier and up 8.1% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.
Context
- Total current liabilities amounted to 30.9% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -2.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 666.49M USD
- Year-over-year change
- -0.4%
- 4-year CAGR
- +7.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 666.49M | -0.4% |
| FY2024 | 2024-12-31 | 669.03M | +10.1% |
| FY2023 | 2023-12-31 | 607.87M | -9.4% |
| FY2022 | 2022-12-31 | 670.65M | +34.0% |
| FY2021 | 2021-12-31 | 500.48M | — |
Total Current Liabilities vs competitors
How SCL compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -2.6% is the 10th highest of 11, against a peer median of +17.0%.
- Total current liabilities amounts to 30.9% of total assets for SCL, versus a peer median of 12.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$36.46B BRL | +40.8% | +18.5% | 48.6% | |
| Mar 2026 | $720.45M USD | -2.6% | -0.2% | 30.9% | |
| Mar 2026 | $532.03M USD | +11.1% | -13.4% | 35.0% | |
| Mar 2026 | $318.03M USD | -2.4% | -18.0% | 20.0% | |
| Mar 2026 | $246.5M USD | -6.0% | -11.2% | 13.1% | |
| Mar 2026 | $127.9M USD | +22.9% | -2.3% | 10.3% | |
| Mar 2026 | $98.57M USD | -0.4% | -8.4% | 9.7% | |
| Mar 2026 | $96.67M USD | +113.6% | -8.8% | 9.9% | |
| Mar 2026 | $70.37M USD | +759.7% | +156.5% | 12.0% | |
| Apr 2026 | $65.32M USD | +53.4% | +11.3% | 8.1% | |
| Apr 2026 | $59.92M USD | +3.9% | +12.6% | 14.7% | |
| Peer median (excluding SCL) | — | +17.0% | -5.4% | 12.5% | |
Competitors are the stored peer set for SCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 159.19M | 173.75M | 129.82M | 99.67M | 132.69M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 419.54M | 436.91M | 422.05M | 388.03M | 387.96M |
| Inventory | 305.54M | 402.53M | 265.56M | 288.72M | 298.83M |
| Other Current Assets | 29.1M | 31.61M | 34.45M | 34.02M | 39.49M |
| Total Current Assets | 913.37M | 1.04B | 851.88M | 810.43M | 858.96M |
| Property, Plant & Equipment (Net) | 850.6M | 1.07B | 1.28B | 1.27B | 1.28B |
| Goodwill | 97.19M | 95.92M | 97.44M | 91.37M | 92.57M |
| Intangible Assets | 60.78M | 58.03M | 52.57M | 42.67M | 39.53M |
| Long-term Investments | 34.5M | 23.29M | 26.8M | 25.56M | 21.27M |
| Tax Assets | (192.47M) | 10.18M | 0 | 0 | 43.74M |
| Other Non-current Assets | 301.64M | 127.65M | 57.34M | 64.69M | 19.52M |
| Total Non-current Assets | 1.15B | 1.39B | 1.51B | 1.49B | 1.5B |
| Total Assets | 2.07B | 2.43B | 2.36B | 2.3B | 2.36B |
| Account Payables | 323.36M | 375.73M | 233.03M | 258.79M | 261.72M |
| Short-term Debt | 40.72M | 132.11M | 252.9M | 292.81M | 300.73M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 57.66M |
| Total Current Liabilities | 500.48M | 670.65M | 607.87M | 669.03M | 666.49M |
| Long-term Debt | 322.86M | 455.03M | 401.25M | 332.63M | 340.98M |
| Deferred Tax Liabilities | 12.49M | 10.18M | 10.37M | 9.61M | 11.45M |
| Deferred Revenue (Non-current) | 9.98M | 8.76M | 6.65M | 4.43M | 2.22M |
| Other Non-current Liabilities | 88.94M | 71.93M | 62.7M | 61.61M | 43.22M |
| Total Non-current Liabilities | 490.94M | 596.46M | 538.99M | 465.68M | 447.2M |
| Total Liabilities | 991.42M | 1.27B | 1.15B | 1.13B | 1.11B |
| Common Stock | 26.76M | 26.84M | 27.01M | 27.16M | 27.3M |
| Retained Earnings | 1.13B | 1.25B | 1.26B | 1.27B | 1.29B |
| Accumulated OCI | (153.24M) | (167.51M) | (130.6M) | (196.84M) | (138.97M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.07B | 1.17B | 1.22B | 1.17B | 1.24B |
| Total Debt | 420.25M | 637.7M | 712.17M | 682.83M | 691.04M |
| Net Debt | 261.06M | 463.95M | 582.35M | 583.17M | 558.35M |
Stepan Company
NYSE:SCL
Intrinsic Alpha fair value
Locked
Current Price
$66.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.